WHO Global Status Report on Cancer 2026, Key Findings

Recently released, the WHO Global Status Report on Cancer 2026 highlights the rising global cancer burden, widening inequalities in cancer care, and the urgent need to strengthen prevention, early detection, treatment, and health systems. The report calls for a comprehensive, people-centred approach to reduce cancer-related deaths and ensure equitable access to quality cancer care.

About Global Status Report on Cancer 2026 

The Global Status Report on Cancer 2026 provides a comprehensive assessment of the global cancer burden, regional trends, healthcare preparedness, and policy responses. It also identifies priority actions needed to improve cancer prevention, diagnosis, treatment, survivorship, and palliative care.

• Published by: Jointly released by the World Health Organization (WHO) and the International Agency for Research on Cancer (IARC).
• Objective: To assess the global burden of cancer and evaluate progress in cancer prevention and control.
• Coverage: Analyses cancer incidence, mortality, survival, healthcare access, policy initiatives, and regional disparities.
• Approach: Highlights both the medical and socio-economic dimensions of cancer and promotes a people-centred approach to cancer care.
• Purpose: Supports countries in designing stronger policies to achieve equitable and effective cancer control.

Global Status Report on Cancer 2026 Key Highlights 

The Global Status Report on Cancer 2026 highlights that cancer is becoming an increasingly important public health and development challenge across the world.

• Around 20.6 million new cancer cases and nearly 10 million deaths occur every year, making cancer the second leading cause of death globally after cardiovascular diseases.
• Annual cancer cases could rise to nearly 35 million by 2050 unless countries strengthen prevention, early diagnosis, and treatment.
• More than 26,000 people die from cancer every day worldwide.
• Asia accounts for more than half of global cancer cases and deaths, while Europe contributes around 21% of cases and 20% of deaths despite having only about 9% of the world’s population.
• Lung cancer remains the leading cause of cancer deaths globally. Among men, lung, prostate, and colorectal cancers are the most common, while breast, lung, and colorectal cancers account for the highest burden among women.
• Around 2.4 million women were diagnosed with breast cancer and nearly 694,000 died from the disease in 2024.
• Nearly 87% of women diagnosed with breast cancer survive for at least five years in high-income countries, compared with only 42% in low-income countries.
• Fewer than one-third of countries currently include comprehensive cancer care under Universal Health Coverage (UHC).
• Availability of the 20 priority cancer medicines ranges from 9–54% in low- and lower-middle-income countries compared with 68–94% in high-income countries.

The report notes encouraging progress in global cancer governance. Around 82% of countries now have National Cancer Control Plans (NCCPs), a significant increase from 50% in 2010. This reflects growing political commitment to cancer prevention and control through comprehensive strategies covering prevention, early detection, treatment, palliative care, research, and health system strengthening. However, the report emphasises that many countries still face challenges in effectively implementing these plans due to limited financial resources, infrastructure, and trained healthcare professionals.

‹ ›

Reasons for Rising Cancer Cases Worldwide

The report attributes the rising global cancer burden to a combination of demographic changes, unhealthy lifestyles, environmental factors, infections, and gaps in prevention.

• Population ageing: Rising life expectancy has increased the number of people living to ages where the risk of developing cancer is higher.
• Lifestyle-related risk factors: Increasing tobacco use, alcohol consumption, unhealthy diets, obesity, and physical inactivity are driving the incidence of several cancers.
• Infection-related cancers: Infections such as Human Papillomavirus (HPV), Hepatitis B, Hepatitis C, and Helicobacter pylori continue to account for a significant proportion of cancer cases worldwide.
• Environmental exposures: Growing exposure to air pollution and other environmental carcinogens is contributing to the increasing cancer burden.
• Urbanisation and changing lifestyles: Rapid urbanisation and changing consumption patterns have increased exposure to behavioural risk factors associated with non-communicable diseases.
• Slow progress in prevention: Although tobacco control, vaccination programmes, and public health policies have reduced certain cancer risks, progress has not kept pace with emerging challenges such as obesity, sedentary lifestyles, and environmental pollution.
• Preventable risk factors remain widespread: The report estimates that nearly four in ten cancer cases are linked to preventable risk factors, highlighting the need for stronger preventive healthcare and health promotion measures.

Impact of Rising Cancer Burden

The rising global cancer burden has significant health, economic, social, and developmental consequences, affecting individuals, healthcare systems, and societies worldwide.

• Health Impact: Cancer has become the second leading cause of death globally, increasing premature mortality and putting pressure on healthcare systems.
• Healthcare System Burden: Rising cancer cases increase demand for diagnostic facilities, oncology specialists, treatment centres, and palliative care services.
• Economic Impact: High treatment costs and productivity losses create financial hardship for patients, families, and healthcare systems.
• Social Impact: Cancer affects quality of life by causing mental health challenges, emotional stress among patients, and increased burden on caregivers.
• Health Inequality: Unequal access to prevention, early diagnosis, treatment, and medicines leads to lower survival rates in low- and middle-income countries.
• Developmental Impact: The growing cancer burden threatens progress towards Universal Health Coverage (UHC) and Sustainable Development Goal 3 (Good Health and Well-being) by widening health disparities.

Cancer Burden in India

India is witnessing a steady rise in cancer cases, making it one of the country’s fastest-growing public health challenges.

• India reports around 15.6 lakh new cancer cases and nearly 8.7 lakh cancer deaths every year.
• Cancer is the second leading cause of death after cardiovascular diseases.
• Breast cancer is the most common cancer among women, while oral cancer remains the leading cancer among men due to widespread tobacco use.
• Other common cancers include lung, cervical, oesophageal, stomach, and colorectal cancers.
• The North-Eastern States, particularly Mizoram, Nagaland, Meghalaya, Arunachal Pradesh, and Assam, record some of the highest cancer incidence rates in the world, especially for tobacco-related cancers.
• Nearly 60-70% of patients are diagnosed at advanced stages, reducing survival and increasing treatment costs.

Government Initiatives

The Government of India has adopted a multi-dimensional approach to cancer control by focusing on prevention, early detection, affordable treatment, and strengthening healthcare infrastructure.

• National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD) for screening and early detection.
• Expansion of Tertiary Care Cancer Centres across the country.
• Financial protection through Ayushman Bharat – PM-JAY.
• Affordable medicines through Jan Aushadhi Kendras and AMRIT Pharmacies.
• Customs duty exemptions on several life-saving cancer medicines.

Challenges in Cancer Control

Despite growing policy attention and improvements in cancer care, several structural and systemic challenges continue to hinder effective cancer prevention, diagnosis, treatment, and survival.

• Inadequate cancer surveillance: Cancer is not a notifiable disease in India, while gaps in death registration and cause-of-death certification affect accurate estimation of the disease burden.
• Late diagnosis: Low public awareness, limited screening, and delayed health-seeking behaviour result in a large proportion of patients being diagnosed at advanced stages.
• Unequal access to healthcare: Access to specialised doctors, diagnostic facilities, and advanced cancer treatment remains concentrated in major urban centres, creating significant regional disparities.
• High treatment costs: Expensive diagnosis, treatment, and long-term care continue to impose a heavy financial burden on patients and their families.
• Shortage of infrastructure and manpower: Many countries, particularly low- and middle-income countries, face shortages of oncology specialists, cancer centres, diagnostic facilities, and essential medicines.
• Persistent global inequalities: Significant disparities continue in access to prevention, early diagnosis, treatment, palliative care, and supportive care between high-income and low-income countries.
• Growing pressure on health systems: The rising number of cancer cases is placing increasing pressure on healthcare infrastructure, workforce, and public health financing.
• Need for stronger prevention: Although tobacco control and vaccination programmes have expanded, prevention efforts remain insufficient to address emerging risk factors such as obesity, unhealthy diets, physical inactivity, and environmental pollution.

Global Status Report on Cancer 2026 Key Recommendations

The Global Status Report on Cancer 2026 recommends a comprehensive and integrated approach focused on prevention, early detection, equitable access to care, and strengthening health systems to reduce the global cancer burden.

• Strengthen Prevention: Reduce tobacco and alcohol consumption, promote healthy diets and physical activity, expand HPV and Hepatitis B vaccination, and minimise exposure to environmental and occupational carcinogens.
• Promote Early Detection: Expand cancer screening programmes, improve awareness about early symptoms, and strengthen diagnostic and pathology services.
• Ensure Equitable Cancer Care: Integrate comprehensive cancer services into Universal Health Coverage (UHC) and improve access to affordable diagnosis, treatment, palliative care, and essential medicines.
• Strengthen Health Systems: Invest in oncology infrastructure, trained healthcare professionals, cancer surveillance systems, registries, research, and innovation.
• Adopt a People-Centred Approach: Provide financial protection, integrate mental health and psychosocial support into cancer care, recognise the role of caregivers, and involve cancer survivors in policy-making.